SI3843702T1 - Kombinacija memantina in donepezila v fiksnem odmerku s takojšnjim sproščanjem - Google Patents

Kombinacija memantina in donepezila v fiksnem odmerku s takojšnjim sproščanjem

Info

Publication number
SI3843702T1
SI3843702T1 SI202030282T SI202030282T SI3843702T1 SI 3843702 T1 SI3843702 T1 SI 3843702T1 SI 202030282 T SI202030282 T SI 202030282T SI 202030282 T SI202030282 T SI 202030282T SI 3843702 T1 SI3843702 T1 SI 3843702T1
Authority
SI
Slovenia
Prior art keywords
memantine
donepezil
immediate release
dose combination
release fixed
Prior art date
Application number
SI202030282T
Other languages
English (en)
Inventor
Machuco Estevens Maria Catarina Oliveira
Marques Da Costa Ricardo Manuel Silva
Serra Joao Pedro Silva
Filipe Augusto Eugenio Pardal
Original Assignee
Technimede, Sociedade Tecnico-Medicinal, SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technimede, Sociedade Tecnico-Medicinal, SA filed Critical Technimede, Sociedade Tecnico-Medicinal, SA
Publication of SI3843702T1 publication Critical patent/SI3843702T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI202030282T 2019-05-31 2020-05-29 Kombinacija memantina in donepezila v fiksnem odmerku s takojšnjim sproščanjem SI3843702T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT11555719 2019-05-31
PCT/IB2020/055137 WO2020240505A1 (en) 2019-05-31 2020-05-29 Immediate release fixed-dose combination of memantine and donepezil
EP20732664.6A EP3843702B1 (en) 2019-05-31 2020-05-29 Immediate release fixed-dose combination of memantine and donepezil

Publications (1)

Publication Number Publication Date
SI3843702T1 true SI3843702T1 (sl) 2023-12-29

Family

ID=71092565

Family Applications (1)

Application Number Title Priority Date Filing Date
SI202030282T SI3843702T1 (sl) 2019-05-31 2020-05-29 Kombinacija memantina in donepezila v fiksnem odmerku s takojšnjim sproščanjem

Country Status (13)

Country Link
EP (2) EP4238555A3 (sl)
BR (1) BR112021024054A2 (sl)
CL (1) CL2021002911A1 (sl)
CO (1) CO2021014967A2 (sl)
DK (1) DK3843702T3 (sl)
FI (1) FI3843702T3 (sl)
HR (1) HRP20231200T1 (sl)
IL (1) IL288505A (sl)
MX (1) MX2021014673A (sl)
PE (1) PE20220936A1 (sl)
PT (1) PT3843702T (sl)
SI (1) SI3843702T1 (sl)
WO (1) WO2020240505A1 (sl)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
ATE94384T1 (de) 1989-04-14 1993-10-15 Merz & Co Gmbh & Co Verwendung von adamantan-derivaten zur praevention und behandlung der cerebralen ischaemie.
WO1997046526A1 (en) 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
JP2005528431A (ja) 2002-05-31 2005-09-22 ハー・ルンドベック・アクチエゼルスカベット アルツハイマー病を治療するためのｎｍｄａ−アンタゴニスト及びアセチルコリンエステラーゼ阻害剤の組み合わせ物
UA83645C2 (ru) 2002-10-24 2008-08-11 Мерц Фарма Гмбх Унд Ко. Кгаа Фармацевтический продукт, который содержит производное 1-аминоциклогексана и ингибитор ацетилхолинестеразы, его применение
WO2006076562A1 (en) 2005-01-11 2006-07-20 Teva Pharmaceutical Fine Chemicals S.R.L. Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
CA2604052C (en) 2005-04-06 2014-07-08 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of cns-related conditions
WO2018062941A1 (ko) * 2016-09-30 2018-04-05 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법

Also Published As

Publication number Publication date
HRP20231200T1 (hr) 2024-01-19
EP3843702A1 (en) 2021-07-07
PE20220936A1 (es) 2022-05-31
WO2020240505A1 (en) 2020-12-03
CO2021014967A2 (es) 2021-11-19
EP3843702B1 (en) 2023-07-05
CL2021002911A1 (es) 2022-07-15
EP4238555A3 (en) 2023-09-20
EP4238555A2 (en) 2023-09-06
PT3843702T (pt) 2023-10-13
IL288505A (en) 2022-01-01
DK3843702T3 (da) 2023-10-09
FI3843702T3 (fi) 2023-10-09
BR112021024054A2 (pt) 2022-01-11
MX2021014673A (es) 2022-01-11

Similar Documents

Publication Publication Date Title
IL257015B (en) Pharmaceutical combination of 2mdm inhibitor and 2bcl inhibitor
EP3578204A4 (en) BIOACTIVE SUBSTANCE CONJUGATE WITH ENHANCED DURABILITY AND ITS USE
IL269236A (en) Engineered amphiphilic antimicrobial peptides and methods of use
IL288372A (en) Modified release preparation and uses thereof
GB201812339D0 (en) Reconcilliation of run-time and configuration discrepancies
SG10202113199RA (en) Dementia therapeutic agent combining pyrazoloquinoline derivative and memantine
IL277129A (en) Human papillomavirus vaccines and their uses
EP3448362A4 (en) EXTENDED RELEASE FORMULATION AND USE THEREOF
IL269305A (en) Cannabinoid formulations and dosage
GB2574954B (en) Tissue scaffold and scaffold composition
GB2615479B (en) Therapeutic and prophylactic use of microoganisms
IL288505A (en) Immediate release in a fixed dose of memantine and donepezil
PL3843702T4 (pl) Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce
SG10202108219QA (en) Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease
GB2600270B (en) Polymer-comrprising medical devices and uses thereof
EP4069233A4 (en) PHARMACEUTICAL COMBINATION AND USE THEREOF
IL277441A (en) Variants of LFA3 and their preparations and uses
ZA201905343B (en) Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition
EP3727347A4 (en) LONG-RELEASE MIDODRINE HYDROCHLORIDE COMPOSITIONS AND METHODS OF USE
EP3730138A4 (en) DRUG CONTAINING A COMBINATION OF SEPETAPROST AND RHO-KINASE INHIBITOR
IL292646A (en) Pharmaceutical combination and its use
EP3888636A4 (en) EUTECTIC DONEPEZI MIX AND USE THEREOF
GB202313260D0 (en) Modified release formulation comprising withanolides
PT3694557T (pt) Excipientes modificadores de libertação à base de amido e composições farmacêuticas derivadas dos mesmos
IL291543A (en) Medical preparations and their use